Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026

Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026

Monday, March 30: Phase 1 data on TNX-4800 (long-acting anti-Borrelia OspA human monoclonal antibody) for the seasonal prevention of Lyme disease  ...

Monday, March 30: Phase 1 data on TNX-4800 (long-acting anti-Borrelia OspA human monoclonal antibody) for the seasonal prevention of Lyme disease  Wednesday, April 1: Animal and in vitro studies on … [+10417 chars]
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026 - FHMnews